Neurogene Inc Capital Reinvestment Ratio

Latest as of June 2018: 0.00x

Neurogene Inc capital reinvestment ratio. Neurogene Inc (NGNE) has a Capital Reinvestment Ratio of 0.00x as of June 2018, meaning it reinvests 0% of its operating cash flow ($9.25 Million) in capital expenditures ($28.31K). Check NGNE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$9.25 Million

USD

Capital Expenditures

$28.31K

USD

Data as of

Jun 2018

Most recent filing

Neurogene Inc Capital Reinvestment Ratio by Year (None–None)

Neurogene Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see NGNE cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow